A Study to Evaluate the Efficacy and Safety of Upadacitinib in Subjects With Takayasu Arteritis (TAK)
Status:
Recruiting
Trial end date:
2026-09-22
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the efficacy of upadacitinib in combination
with a corticosteroid taper regimen compared to placebo in combination with a corticosteroid
taper regimen.